Diagenode

MethylCap kit

4 publications found.

Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA
Published: November, 2021

Abstract: Cell-free DNA (cfDNA) methylation has emerged as a promising biomarker for early cancer detection, tumor type classification, and treatment response monitoring. Enrichment-based cfDNA methylation profiling methods such as cfMeDIP-seq have shown hi...
Read more »

Transcriptome and Methylome Analysis Reveal ComplexCross-Talks between Thyroid Hormone and GlucocorticoidSignaling at Xenopus Metamorphosis.
Published: September, 2021

Abstract: BACKGROUND: Most work in endocrinology focus on the action of a single hormone, and very little on the cross-talks between two hormones. Here we characterize the nature of interactions between thyroid hormone and glucocorticoid signaling during me...
Read more »

Cell-free DNA methylome profiling by MBD-seq with ultra-low input
Published: March, 2021

Abstract: Methylation signatures in cell-free DNA (cfDNA) have shown great sensitivity and specificity in the characterization of tumour status and classification of tumour types, as well as the response to therapy and recurrence. Currently, most cfDNA meth...
Read more »

Genome-wide DNA methylation and RNA-seq analyses identify genes andpathways associated with doxorubicin resistance in a canine diffuse largeB-cell lymphoma cell line.
Published: January, 2021

Abstract: Doxorubicin resistance is a major challenge in the successful treatment of canine diffuse large B-cell lymphoma (cDLBCL). In the present study, MethylCap-seq and RNA-seq were performed to characterize the genome-wide DNA methylation and differenti...
Read more »

ニュース

 すべてのニュースを見る


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics